COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 775: Articles 7741-7750  | Next

The impact of community asymptomatic rapid antigen testing on COVID-19 hospital admissions: a synthetic control study
Zhang, X., Barr, B., Green, M., Hughes, D., Ashton, M., Charalampopoulos, D., Garcia-Finana, M., Buchan, I.
10.1101/2022.04.19.22274050 — Posted: 2022-04-21
Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study
Seekircher, L., Banki, Z., Kimpel, J., Roessler, A., Schaefer, H., Falkensammer, B., Bante, D., Forer, L., Schoenherr, S., Harthaller, T., Sacher, M., Ower, C., Tschiderer, L., Ulmer, H., Krammer, F., von Laer, D., Borena, W., Willeit, P.
10.1101/2022.04.19.22273872 — Posted: 2022-04-21
Genetic diversity and spatiotemporal distribution of SARS-CoV-2 alpha variant in India
Parasar, J., Pandey, R. K., Patel, Y., Singh, P. P., Srivastava, A., Mishra, R., Kumar, B., Rai, N., Mishra, V. N., Shrivastava, P., Suravajhala, P., Chaubey, G.
10.1101/2022.04.20.22274084 — Posted: 2022-04-21
A Statistical Argument Against Vaccine Injury
Balayla, J.
10.1101/2022.04.19.22274036 — Posted: 2022-04-21
A Platform for Data-centric, Continuous Epidemiological Analyses
Coelho, F. C., Camara, D. C. P., Araujo, E. C., Bianchi, L., Ogasawara, I., Dalal, J., James, A., Abbate, J. L., Merzouki, A., Reis, I., Nwosu, K. D., Keiser, O.
10.1101/2022.04.19.22274026 — Posted: 2022-04-21
Elevated plasma Complement Factor H Regulating Protein 5 is associated with venous thromboembolism and COVID-19 severity
Sanchez-Rivera, L., Iglesias, M. J., Ibrahim-Kosta, M., Kral- Pointner, J. B., Havervall, S., Goumidi, L., Farm, M., Munsch, G., Germain, M., Smith, P., Hong, M.-G., Suchon, P., Naudin, C., Boland, A., Smadja, D. M., Holmstrom, M., Magnusson, M., Silveira, A., Uhlen, M., Renne, T., Martinez-Perez, A., Emmerich, J., Deleuze, J.-F., Antovic, J., Assinger, A., Soria Fernandez, J. M., Thalin, C., Schwenk, J. M., Souto Andres, J. C., Morange, P.-E., Butler, L. M., Tregouet, D. A., Odeberg, J.
10.1101/2022.04.20.22274046 — Posted: 2022-04-21
Determinants of SARS-CoV-2 anti-spike antibody levels following BNT162b2 vaccination: cross-sectional analysis of 6,000 SIREN study participants
Otter, A. D., D'Arcangelo, S., Whitaker, H., Hewson, J., Foulkes, S., Atti, A., Cole, M., Linley, E., Tonge, S., Hettiarachchi, N., Sajedi, N., Calbraith, D., Norman, C., de Lacy, E., Price, L., Stewart, S., Cromey, L., Corrigan, D., SIREN study group, , Rowe, C., Brown, C., Islam, J., Semper, A., Hopkins, S., Hall, V., Brooks, T.
10.1101/2022.04.21.22274025 — Posted: 2022-04-21
Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy
McCreary, E. K., Lemon, L., Megli, C., Oakes, A., Zapf, R. L., Kip, P. L., Seymour, C. W., UPMC Magee Monoclonal Antibody Treatment Group
10.1101/2022.04.20.22274090 — Posted: 2022-04-21
Accuracy of US CDC COVID-19 Forecasting Models
Chharia, A., Jeevan, G., Jha, R. A., Liu, M., Berman, J. M., Glorioso, C. A.
10.1101/2022.04.20.22274097 — Posted: 2022-04-21
The statistical analysis of daily data associated with different parameters of the New Coronavirus COVID-19 pandemic in Georgia and their monthly interval prediction from January 1, 2022 to March 31, 2022
Amiranashvili, A. G., Khazaradze, K. R., Japaridze, N. D.
10.1101/2022.04.19.22274044 — Posted: 2022-04-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).